{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:01:21Z","timestamp":1780606881708,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biotechnology (DBT), Government of India","award":["BT\/PR5638\/MED\/29\/580\/2012"],"award-info":[{"award-number":["BT\/PR5638\/MED\/29\/580\/2012"]}]},{"name":"Senior Research Fellow (SRF)"},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.micpath.2018.11.029","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T12:05:04Z","timestamp":1542974704000},"page":"399-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts"],"prefix":"10.1016","volume":"126","author":[{"given":"Kirti","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Medha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2018.11.029_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001237","article-title":"Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines","volume":"6","author":"Gideon","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2018.11.029_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","article-title":"Tuberculosis vaccines--rethinking the current paradigm","volume":"35","author":"Andersen","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tim.2006.11.008","article-title":"Vaccine strategies against latent tuberculosis infection","volume":"15","author":"Andersen","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2018.11.029_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2015.00217","article-title":"Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination","volume":"6","author":"Boer","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chom.2011.11.012","article-title":"Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells","volume":"11","author":"Blomgran","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2018.11.029_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2018.11.029_bib7","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/eji.201141602","article-title":"Double- and monofunctional CD4(+) and CD8(+) T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals","volume":"41","author":"Commandeur","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.5588\/ijtld.12.0695","article-title":"Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan","volume":"17","author":"Hozumi","year":"2013","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.micpath.2018.11.029_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018523","article-title":"Novel vaccination strategies against tuberculosis","volume":"4","author":"Andersen","year":"2014","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"10.1016\/j.micpath.2018.11.029_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines--state of the art, and novel approaches to vaccine development","volume":"32","author":"da Costa","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.11.029_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijmyco.2015.10.005","article-title":"Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach","volume":"5","author":"Pandey","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.micpath.2018.11.029_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/cbdd.12840","article-title":"Characterization of MymA protein as a flavin\u2010containing monooxygenase and as a target of isoniazid","volume":"89","author":"Saraav","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.micpath.2018.11.029_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/icb.2008.97","article-title":"Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells","volume":"87","author":"Sharma","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.micpath.2018.11.029_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00693.x","article-title":"Early T-cell responses in tuberculosis immunity","volume":"225","author":"Winslow","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2018.11.029_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00517","article-title":"Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis","volume":"5","author":"Serra-Vidal","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2018.11.029_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18097\/pbmc20115701014","article-title":"Synthetic peptide vaccines","volume":"57","author":"Moisa","year":"2011","journal-title":"Biomed. Khim."},{"key":"10.1016\/j.micpath.2018.11.029_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.micpath.2018.11.029_bib18","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.micinf.2006.03.018","article-title":"Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis","volume":"8","author":"Leyten","year":"2006","journal-title":"Microb. Infect."},{"key":"10.1016\/j.micpath.2018.11.029_bib19","series-title":"The New Paradigm of Immunity to Tuberculosis SE - 9","first-page":"165","article-title":"Foxp3+ regulatory T cells in tuberculosis","author":"Larson","year":"2013"},{"key":"10.1016\/j.micpath.2018.11.029_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejcdt.2013.10.013","article-title":"Increased frequency of CD4+CD25+FoxP3+ circulating regulatory T cells (Treg) in tuberculous patients, Egypt","volume":"63","author":"Arram","year":"2014","journal-title":"J. Chest Dis. Tuberc."},{"key":"10.1016\/j.micpath.2018.11.029_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044728","article-title":"Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.11.029_bib22","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/IAI.68.12.6826-6832.2000","article-title":"Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins","volume":"68","author":"Russo","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2018.11.029_bib23","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.178.5.2661","article-title":"Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis","volume":"178","author":"Kursar","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2249.2006.03027.x","article-title":"A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis","volume":"144","author":"Ribeiro-Rodrigues","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.2001.01236.x","article-title":"The many faces of host responses to tuberculosis","volume":"103","author":"Collins","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2018.11.029_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/187153008783928398","article-title":"Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention","volume":"8","author":"Lin","year":"2008","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.micpath.2018.11.029_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tube.2011.12.005","article-title":"T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia","volume":"92","author":"Riano","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2018.11.029_bib28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1128\/CVI.00047-10","article-title":"Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A","volume":"17","author":"de Cassan","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.icb.7100037","article-title":"Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection","volume":"85","author":"Sharma","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.micpath.2018.11.029_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/mi.2011.10","article-title":"Initiation and regulation of T-cell responses in tuberculosis","volume":"4","author":"Urdahl","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2018.11.029_bib31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.tube.2016.05.011","article-title":"Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity","volume":"99","author":"Schrager","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2018.11.029_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/cmi.2015.12","article-title":"Regulatory T cells turn pathogenic","volume":"12","author":"Guo","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.micpath.2018.11.029_bib33","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/IAI.69.7.4320-4328.2001","article-title":"CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis","volume":"69","author":"Serbina","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2018.11.029_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2006.08.003","article-title":"From vanilla to 28 flavors: multiple varieties of T regulatory cells","volume":"25","author":"Shevach","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2018.11.029_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2018.11.029_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"IL-17 and Th17 cells in tuberculosis","volume":"21","author":"Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.micpath.2018.11.029_bib37","first-page":"213","article-title":"Role of cytokines in immune response to pulmonary tuberculosis","volume":"19","author":"Sharma","year":"2001","journal-title":"Asian Pac. J. Allergy Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018309331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018309331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:40:10Z","timestamp":1565253610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018309331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"alternative-id":["S0882401018309331"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2018.11.029","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2018.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}